Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio.
作者信息
Kinirons M T, Krivoruk Y, Wilkinson G R, Wood A J
出版信息
Br J Clin Pharmacol. 1999 Feb;47(2):223-5. doi: 10.1046/j.1365-2125.1999.00859.x.
Abstract
摘要
相似文献
1
Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio.
Br J Clin Pharmacol. 1999 Feb;47(2):223-5. doi: 10.1046/j.1365-2125.1999.00859.x.
2
Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
Clin Pharmacol Ther. 2001 Oct;70(4):305-10.
3
Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.
Clin Pharmacol Ther. 1993 Dec;54(6):621-9. doi: 10.1038/clpt.1993.199.
4
Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.
Clin Pharmacol Ther. 2001 Nov;70(5):446-54.
5
Erythromycin breath test.
Clin Pharmacol Ther. 2000 May;67(5):577-8. doi: 10.1016/S0009-9236(01)90133-X.
6
Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity.
J Clin Pharmacol. 1999 Dec;39(12):1212-20. doi: 10.1177/00912709922012015.
7
Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole.
Am J Clin Oncol. 1997 Dec;20(6):592-9. doi: 10.1097/00000421-199712000-00013.
8
Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells.
Eur J Pharmacol. 1998 Oct 9;358(3):289-94. doi: 10.1016/s0014-2999(98)00607-4.
9
Cytochrome P-450 and other determinants of pharmacokinetics, toxicity, and efficacy in humans.
Clin Cancer Res. 2000 Apr;6(4):1203-4.
10
Race but not age affects erythromycin breath test results in older hypertensive men.
J Clin Pharmacol. 2001 Mar;41(3):324-9. doi: 10.1177/00912700122010023.
引用本文的文献
1
Breath tests to phenotype drug disposition in oncology.
Clin Pharmacokinet. 2013 Nov;52(11):919-26. doi: 10.1007/s40262-013-0099-9.
2
Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosterone.
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jul;370(1):71-7. doi: 10.1007/s00210-004-0944-3. Epub 2004 Jul 1.
3
The erythromycin breath test for the prediction of drug clearance.
Clin Pharmacokinet. 2001;40(3):151-8. doi: 10.2165/00003088-200140030-00001.
4
Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
Clin Pharmacokinet. 2000 Feb;38(2):111-80. doi: 10.2165/00003088-200038020-00002.
Zotero 插件